StockData
OKYO Pharma Ltd logo

OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.16+0.06 (+5.45%)

Close on Nov 19, 2026Market cap $60.88MP/E –Yield –

OKYO Pharma free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2026 it was -$5.94M. The highest annual figure on record is -$1.61M in fiscal 2021.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$5.94M–
FY2025Mar 31, 2025-$1.81M–
FY2023Mar 31, 2023-$7.70M–
FY2022Mar 31, 2022-$5.47M–
FY2021Mar 31, 2021-$1.61M–

More OKYO Pharma figures

See a number that looks wrong?